ask="0.9800"
ask_size="100"
average_daily_volume="117258"
bid="0.7500"
bid_size="4000"
book_value="0.6940"
change="-0.0399"
change_from_200_day_moving_average="-0.4859"
change_from_50_day_moving_average="-0.2688"
change_from_52_week_high="-2.2499"
change_From_52_week_low="0.0701"
change_in_percent="-4.3370%"
close="0.8801"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.0070"
ebitda="-17.60M"
eps_estimate_current_year="-0.8200"
eps_estimate_next_quarter="-0.2200"
eps_estimate_next_year="-0.7300"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.9480"
high_52_weeks="3.1300"
last_trade_date="3/16/2017"
last_trade_price="0.8801"
last_trade_size="100"
last_trade_time="3:58pm"
low="0.8400"
low_52_weeks="0.8100"
market_capitalization="14.43M"
moving_average_200_day="1.3660"
moving_average_50_day="1.1489"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="0.9200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-35.5696%"
percent_change_from_50_day_moving_average="-23.3956%"
percent_change_from_52_week_high="-71.8818%"
percent_change_from_52_week_low="+8.6543%"
previous_close="0.9200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3256"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.6300"
stock_exchange="NGM"
symbol="ORPN"
volume="97751"
weeks_range_52="0.8100 - 3.1300"
